- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06427603
Sit Less and Move More: Feasibility Study
May 19, 2024 updated by: Dr Bonny WONG Yee Man, Hong Kong Metropolitan University
Sit Less and Move More: A Feasibility Study on Physical Active Break Intervention and Improving Cardiometabolic Health
Intervention aiming to improve cardiometabolic health by reducing prolonged sitting
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ho Man Tin, Hong Kong
- School of Nursing and Health Studies, Hong Kong Metropolitan University
-
Contact:
- Bonny YM Wong, PhD
- Phone Number: (852) 3970 2976
- Email: bymwong@hkmu.edu.hk
-
Principal Investigator:
- Bonny YM Wong, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- are community-dwelling older adults aged 65 years or above,
- are smartphone users,
- sit for >= 6 hours per day
- are overweight
Exclusion Criteria:
- are unable to walk independently with/without walking aids due to a physical disability;
- have health conditions that hinder the adherence to intervention
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: control group
|
|
Experimental: activity group
|
workshops and mobile apps: break sedentary behavior by activity breaks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intervention feasibility
Time Frame: T2: post-intervention (week 12)
|
will be assessed using a scale "Feasibility, appropriateness, and acceptability of the intervention"
|
T2: post-intervention (week 12)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sedentary behavior
Time Frame: T1: baseline (before the study begins)
|
will be assessed using an accelerometer
|
T1: baseline (before the study begins)
|
Sedentary behavior
Time Frame: T2: post-intervention (week 12)
|
will be assessed using an accelerometer
|
T2: post-intervention (week 12)
|
Sarcopenia score ranged from 0 to 20
Time Frame: T1: baseline (before the study begins)
|
will be assessed using the Strength, Assistance with walking, Rise from a chair, Climb stairs and (Calf) Falls (SARC-Calf)
|
T1: baseline (before the study begins)
|
Sarcopenia score ranged from 0 to 20
Time Frame: T2: post-intervention (week 12)
|
will be assessed using the Strength, Assistance with walking, Rise from a chair, Climb stairs and (Calf) Falls (SARC-Calf)
|
T2: post-intervention (week 12)
|
Blood glucose
Time Frame: T1: baseline (before the study begins)
|
will be assessed using a portable blood monitoring device
|
T1: baseline (before the study begins)
|
Blood glucose
Time Frame: T2: post-intervention (week 12)
|
will be assessed using a portable blood monitoring device
|
T2: post-intervention (week 12)
|
Blood lipid
Time Frame: T1: baseline (before the study begins)
|
will be assessed using a portable blood monitoring device
|
T1: baseline (before the study begins)
|
Blood lipid
Time Frame: T2: post-intervention (week 12)
|
will be assessed using a portable blood monitoring device
|
T2: post-intervention (week 12)
|
Blood pressure
Time Frame: T1: baseline (before the study begins)
|
will be assessed using a portable blood monitoring device
|
T1: baseline (before the study begins)
|
Blood pressure
Time Frame: T2: post-intervention (week 12)
|
will be assessed using a portable blood monitoring device
|
T2: post-intervention (week 12)
|
Muscle strength (handgrip strength)
Time Frame: T1: baseline (before the study begins)
|
will be assessed using a hand-held dynamometer
|
T1: baseline (before the study begins)
|
Muscle strength (handgrip strength)
Time Frame: T2: post-intervention (week 12)
|
will be assessed using a hand-held dynamometer
|
T2: post-intervention (week 12)
|
Physical performance
Time Frame: T1: baseline (before the study begins)
|
will be assessed using Time-Up-to-Go (TUG)
|
T1: baseline (before the study begins)
|
Physical performance
Time Frame: T2: post-intervention (week 12)
|
will be assessed using Time-Up-to-Go (TUG)
|
T2: post-intervention (week 12)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2024
Primary Completion (Estimated)
October 1, 2024
Study Completion (Estimated)
January 1, 2025
Study Registration Dates
First Submitted
May 8, 2024
First Submitted That Met QC Criteria
May 19, 2024
First Posted (Actual)
May 24, 2024
Study Record Updates
Last Update Posted (Actual)
May 24, 2024
Last Update Submitted That Met QC Criteria
May 19, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- RD/2022/2.12
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sedentary Behavior
-
Research on Healthcare Performance Lab U1290RecruitingSedentary Behavior | Sedentary Time | Health Behavior | Health-Related Behavior | Physical InactivityFrance
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSedentary Behavior | Sedentary TimeUnited States
-
Loughborough UniversityBritish Heart FoundationCompletedSedentary Lifestyle | Sedentary Behavior | Diet Habit
-
Biruni UniversityCompletedSedentary Behavior | Health BehaviorTurkey
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
The University of Texas Health Science Center,...M.D. Anderson Cancer CenterRecruitingSedentary BehaviorUnited States
-
Universita di VeronaNot yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulNot yet recruitingSedentary BehaviorBrazil
-
School of Health Sciences GenevaCompleted
-
Paracelsus Medical UniversityLudwig Boltzmann Institute for Digital Health and PreventionCompleted
Clinical Trials on physical activity
-
Health Education Research Foundation (HERF)CompletedQuality of LifePakistan
-
Zohra Institute of Health SciencesCompletedPhysical Activity and StressPakistan
-
Centre Hospitalier Universitaire DijonWithdrawn
-
Fundacion para la Investigacion y Formacion en...CompletedImpaired CognitionSpain
-
Cardenal Herrera UniversityRecruiting
-
Istituti Clinici Scientifici Maugeri SpAActive, not recruiting
-
Assaf-Harofeh Medical CenterBen-Gurion University of the NegevUnknown
-
Universidad Santo TomasEmory University; Universidad Pública de Navarra; Universidad de Granada; University... and other collaboratorsCompletedObesity | Lipid Metabolism Disorders | Mental Health Wellness 1 | Body Composition, Beneficial | Metabolic Syndrome X
-
AUSL Romagna RiminiFondazione IRCCS Istituto Nazionale dei Tumori, MilanoRecruitingNon-Small Cell Lung CancerItaly
-
Fundación para la Investigación del Hospital Clínico...CompletedObesity | Severe Mental Disorder